Last update 23 Mar 2025

QHRD-110

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
QHRD-110, QHRD110
Target
CDK4 x CDK6
Action
inhibitors
Mechanism
CDK4 inhibitors(Cyclin-dependent kinase 4 inhibitors), CDK6 inhibitors(Cyclin-dependent kinase 6 inhibitors)
Therapeutic Areas
NeoplasmsNervous System DiseasesOther Diseases
Active Indication
Brain metastasesGlioblastoma MultiformeHigh grade glioma+ [2]
Inactive Indication-
Originator Organization
Changzhou Qianhong Biopharma Co., Ltd.Changzhou Qianhong Biopharma Co., Ltd.
Active Organization
Changzhou Qianhong Biopharma Co., Ltd.Changzhou Qianhong Biopharma Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with QHRD-110
CTR20233705
/ RecruitingPhase 1
一项评估QHRD110单药在复发或进展的中枢神经系统恶性肿瘤中的安全性，耐受性和药代动力学特征的开放标签、剂量递增及扩展的I期研究
[Translation] An open-label, dose-escalation, and expansion phase I study evaluating the safety, tolerability, and pharmacokinetic profile of QHRD110 monotherapy in patients with relapsed or progressive CNS malignancies
100 Clinical Results associated with QHRD-110
Login to view more data
100 Translational Medicine associated with QHRD-110
Login to view more data
100 Patents (Medical) associated with QHRD-110
Login to view more data
100 Deals associated with QHRD-110
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Brain metastasesPhase 1
China
Changzhou Qianhong Biopharma Co., Ltd.Changzhou Qianhong Biopharma Co., Ltd.
09 Jan 2024
Glioblastoma MultiformePhase 1
China
Changzhou Qianhong Biopharma Co., Ltd.Changzhou Qianhong Biopharma Co., Ltd.
09 Jan 2024
High grade gliomaPhase 1
China
Changzhou Qianhong Biopharma Co., Ltd.Changzhou Qianhong Biopharma Co., Ltd.
09 Jan 2024
MedulloblastomaPhase 1
China
Changzhou Qianhong Biopharma Co., Ltd.Changzhou Qianhong Biopharma Co., Ltd.
09 Jan 2024
MeningiomaPhase 1
China
Changzhou Qianhong Biopharma Co., Ltd.Changzhou Qianhong Biopharma Co., Ltd.
09 Jan 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free